Apidra Solostar Sanofi
€241.00
Buying Apidra Solostar Sanofi is easy trusted online store in English
Purchasing Apidra Solostar Sanofi is a straightforward process when you choose a reliable online store. With various platforms now offering this medication, ensuring you select a trusted source is crucial. The advantage of buying online includes the convenience of delivery to your door and potentially better prices. It’s essential to check for certifications and customer reviews to confirm you are dealing with a legitimate pharmacy. Many online stores provide consultations with pharmacists, helping you to make informed decisions. While the ease of access is enticing, being diligent about your choice ensures both safety and effectiveness.
General information about Apidra Solostar Sanofi formulation and presentation
Apidra Solostar is a rapid-acting insulin formulation manufactured by Sanofi. Primarily used to manage blood glucose levels in individuals with diabetes, Apidra is particularly designed for those requiring swift interventions to control post-meal blood sugar spikes. This insulin formulation comes in a convenient pre-filled pen format known as the Solostar. Each pen contains a specific dosage, making it user-friendly for individuals who are on-the-go or prefer an easier administration method compared to vial and syringe. The formulation allows for flexible dosing and is usually administered subcutaneously, ensuring prompt absorption and effectiveness.
The benefits of using a pre-filled pen include:
- Portability for ease of use during travel or sports.
- Built-in dose presetting for accuracy.
- Reduced risk of contamination compared to multi-use vials.
- Eliminates the need for separate syringes.
Mechanism of action effects on metabolism
Apidra works by mimicking the natural insulin produced by the pancreas. As a fast-acting insulin, its onset typically occurs within 10 to 20 minutes after administration, peaking at about 1 hour. This swift action helps control both fasting and post-prandial (post-meal) glucose levels effectively.
The mechanism involves binding to insulin receptors on various tissues, including muscle and adipose tissues, facilitating glucose uptake and storage. This reduces blood sugar levels by enabling cells to utilize glucose for energy. Additionally, Apidra suppresses hepatic glucose production, further contributing to reduced blood glucose concentration. The pharmacokinetics of Apidra are particularly beneficial for athletes who require precise control over their blood sugar levels, enhancing performance and recovery post-exercise.
Benefits faster recovery, greater potency
For athletes and sports enthusiasts, the primary advantage of using Apidra Solostar is its rapid onset of action. This speed allows for immediate management of blood glucose levels before and after intense training sessions. Proper glucose regulation can minimize the fatigue experienced during workouts, thereby improving performance and endurance.
Moreover, Apidra’s formulation enhances the recovery process post-exercise. The prompt absorption of glucose into the muscles after exertion aids glycogen replenishment. This quick recovery leads to reduced muscle soreness and swifter return to peak performance levels. Enhanced metabolic stability and energy levels can be pivotal for athletes, allowing for more consistent training regimens.
Using Apidra can also mean greater flexibility. Unlike other long-acting insulins, Apidra’s dosage can be tailored more easily, accommodating varied training schedules or meal times. This adaptability supports both short- and long-term fitness goals, making it a valuable tool in a sports pharmacology setting.
Contraindications and safety
While Apidra Solostar offers numerous benefits, it is essential to be aware of its contraindications and safety measures. Individuals with hypersensitivity to insulin glulisine or any of the components in the formulation should not use Apidra. Additionally, it is not recommended for individuals experiencing hypoglycemia or those who have been diagnosed with specific conditions that could complicate insulin use.
Safety precautions include regularly monitoring blood sugar levels to prevent both hyperglycemia and hypoglycemia. Caution is advised when engaging in sports or physical activities that could lead to dramatic changes in blood glucose levels. Consulting healthcare providers before starting Apidra is paramount, particularly for athletes combining this medication with performance-enhancing substances or supplements.
In summary, while Apidra Solostar Sanofi presents a powerful solution for glucose management in athletes, adhering to safety guidelines and understanding its proper application greatly enhances the overall health benefits.
| Active substance | Insulin Glulisine |
|---|---|
| Classification | hormone and synthetic substitute / antidiabetic agent |
| Acne | No |
| Water Retention | No |
| HBR | No |
| Hepatotoxicity | No |
| Aromatization | No |
| Lab Test | Blood insulin levels, C-peptide test |
| Also known as | Exogenous insulin |
| WAREHOUSE | International Warehouse 2 |
| Blood pressure | Can indirectly affect blood pressure by altering blood glucose levels |
| Trade name | Humulin, Novolin, Lantus, among others |
| Storage conditions | Must be kept refrigerated (2-8 degrees Celsius), avoid freezing |
| Chemical name | Insulin |
| Formula | C257H383N65O77S6 (for human insulin) |
| Substance class | Hormone, peptide |
| Main action | Lowers blood glucose levels |
| Half-life | Varies by type (Rapid-acting: 2-4 hours, Short-acting: 3-6 hours, Intermediate-acting: 12-18 hours, Long-acting: 20-24 hours) |
| Dosage (medical) | Depends on the patient's insulin sensitivity, carbohydrate intake, and blood glucose level, typically ranges from 0.5 to 1 unit/kg per day |
| Dosage (sports) | Not recommended for non-medical use |
| Effects | Decreases blood glucose, increases cellular glucose uptake, promotes glycogen synthesis |
| Side effects | Hypoglycemia, weight gain, insulin resistance, allergic reactions |
| Use in sports | Misused for anabolic purposes |
| Manufacturer | Sanofi |
| 5 |
|
0 |
| 4 |
|
0 |
| 3 |
|
0 |
| 2 |
|
0 |
| 1 |
|
0 |




Reviews
There are no reviews yet.